The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBAE Systems Regulatory News (BA.)

Share Price Information for BAE Systems (BA.)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,385.50
Bid: 1,385.50
Ask: 1,386.00
Change: -11.50 (-0.82%)
Spread: 0.50 (0.036%)
Open: 1,391.50
High: 1,396.50
Low: 1,378.00
Prev. Close: 1,397.00
BA. Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Directorate Change

2 Apr 2020 07:00

RNS Number : 4944I
BAE SYSTEMS PLC
02 April 2020
 

BAE SYSTEMS PLC - NOTICE OF DIRECTORATE CHANGES

Jane Griffiths to join the Board as a Non-Executive Director

The Board of BAE Systems plc is pleased to announce the appointment of Jane Griffiths as a non-executive director of the Company with effect from 1 April 2020.

Until retiring in December 2019, Jane Griffith enjoyed a long career with Johnson & Johnson, during which she held executive roles in clinical research, international and strategic marketing, product management and operational management. In her last role before retirement, Jane was Global Head of Actelion, where she led the integration of the Swiss biotech business following its acquisition by Johnson & Johnson. Prior to that she had been Company Group Chair of Janssen EMEA, the group's research based pharmaceutical arm. During her time with Johnson & Johnson she led its Corporate Citizen Trust in EMEA and sponsored its Women's Leadership Initiative. She was also sponsor of Janssen's Global Pharmaceuticals Sustainability Council.Jane is a past chair of the Executive Committee of the European Federation of Pharmaceutical Industries and Associations, past Chairwoman of the PhRMA Europe Committee and former member of the Corporate Advisory Board of the UK Government backed 'Your Life' campaign, aimed at encouraging more people to study STEM subjects.

She is currently a non-executive director of Johnson Matthey Plc and a member of the board of directors of TB Alliance, a not-for-profit organisation dedicated to the discovery, development and delivery of better, faster acting and affordable tuberculosis drugs that are available to those who need them.Sir Roger Carr, Chairman of BAE Systems plc, said: "I am delighted that Jane Griffiths has joined the BAE Systems Board. She has an impressive record of leading research-led, high technology businesses and brings a wealth of international corporate experience to the Board. Her advocacy and support for women business leaders is particularly noteworthy and relevant in helping us make further progress against our own diversity and inclusion objectives."

Jane Griffiths has no details to disclose under Listing Rule 9.6.13.

Nick Rose term of appointment

The Board is pleased to confirm that Nick Rose has agreed to extend his term of appointment as a Non-Executive Director of the Company for up to one further year in order to support the Company through a challenging period associated with the Coronavirus crisis. His knowledge of the Company accumulated over the last ten years as a Board member, and his past roles as Chair of the Audit Committee and Senior Independent Director, will be invaluable in navigating the Company through these uncharted waters.

Current Board MembershipAs previously announced, Tom Arseneault and Brad Greve also joined the Board on 1 April 2020; Tom has succeeded Jerry DeMuro as President & CEO of BAE Systems, Inc., and Brad has succeeded Peter Lynas as Group Finance Director.

Following the above changes, the composition of the BAE Systems Board is as follows:

Chairman and Executive DirectorsSir Roger Carr - ChairmanCharles Woodburn - Chief ExecutiveTom Arseneault - President & CEO, BAE Systems, Inc.Brad Greve - Group Finance DirectorNon-Executive Directors Revathi AdvaithiElizabeth CorleyJane GriffithsChris GriggStephen PearceNicole PiaseckiPaula Rosput ReynoldsNick RoseIan Tyler

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
BOASSMFWFESSEEL
Date   Source Headline
28th Mar 20244:38 pmRNSDirector/PDMR Shareholding
28th Mar 202411:25 amRNSDirector Declaration
28th Mar 202410:50 amRNSTotal Voting Rights
27th Mar 20245:25 pmRNSTransaction in Own Shares
26th Mar 20245:04 pmRNSTransaction in Own Shares
25th Mar 20245:14 pmRNSTransaction in Own Shares
22nd Mar 20245:33 pmRNSTransaction in Own Shares
21st Mar 20246:22 pmRNSTransaction in Own Shares
21st Mar 20242:03 pmRNSDirector/PDMR Shareholding
20th Mar 20245:52 pmRNSTransaction in Own Shares
20th Mar 202412:22 pmRNSDirector/PDMR Shareholding
20th Mar 20249:15 amRNSNotes Issuance
19th Mar 20245:43 pmRNSTransaction in Own Shares
18th Mar 20245:46 pmRNSTransaction in Own Shares
15th Mar 20245:50 pmRNSTransaction in Own Shares
15th Mar 202412:31 pmRNSDirector/PDMR Shareholding
14th Mar 20246:11 pmRNSTransaction in Own Shares
13th Mar 20245:20 pmRNSTransaction in Own Shares
12th Mar 20245:06 pmRNSTransaction in Own Shares
11th Mar 20246:26 pmRNSTransaction in Own Shares
11th Mar 202412:30 pmRNSDirector/PDMR Shareholding
8th Mar 20245:26 pmRNSTransaction in Own Shares
7th Mar 20246:21 pmRNSTransaction in Own Shares
7th Mar 20249:00 amRNSPublication of 2023 Annual Report
6th Mar 20245:10 pmRNSTransaction in Own Shares
5th Mar 20246:06 pmRNSTransaction in Own Shares
5th Mar 20242:32 pmRNSNotice of Results
4th Mar 20244:57 pmRNSTransaction in Own Shares
1st Mar 20245:10 pmRNSTransaction in Own Shares
29th Feb 20245:11 pmRNSTransaction in Own Shares
29th Feb 20242:47 pmRNSTotal Voting Rights
29th Feb 202410:49 amRNSDirector/PDMR Shareholding
28th Feb 20245:14 pmRNSTransaction in Own Shares
27th Feb 20244:54 pmRNSTransaction in Own Shares
26th Feb 20246:09 pmRNSTransaction in Own Shares
23rd Feb 20246:07 pmRNSTransaction in Own Shares
22nd Feb 20246:11 pmRNSTransaction in Own Shares
21st Feb 20246:06 pmRNSTransaction in Own Shares
21st Feb 20247:00 amRNSFinal Results
20th Feb 20246:13 pmRNSTransaction in Own Shares
19th Feb 20245:06 pmRNSTransaction in Own Shares
16th Feb 20244:59 pmRNSTransaction in Own Shares
16th Feb 20242:59 pmRNSCompletion of Ball Aerospace acquisition
15th Feb 20245:02 pmRNSTransaction in Own Shares
15th Feb 20242:34 pmRNSDirector/PDMR Shareholding
14th Feb 20246:09 pmRNSTransaction in Own Shares
14th Feb 202412:03 pmRNSRegulatory Approval for Ball Aerospace acquisition
13th Feb 20246:08 pmRNSTransaction in Own Shares
9th Feb 20246:10 pmRNSTransaction in Own Shares
8th Feb 20245:24 pmRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.